The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Updated results.
 
Andreas Nicholas Saltos
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Tawee Tanvetyanon
No Relationships to Disclose
 
Eric B. Haura
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen Oncology
Research Funding - Boehringer Ingelheim; FORMA Therapeutics; Ignyta; Janssen; Lilly
Patents, Royalties, Other Intellectual Property - Patent pending on PLA technology related to kinase inhibitor sensitivity biomarkers
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Ben C. Creelan
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene
Speakers' Bureau - ARIAD; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Scott Joseph Antonia
Stock and Other Ownership Interests - Cellular Biomedicine Group
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cellular Biomedicine Group; Memgen; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; FLX Bio; Memgen; Merck; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; FLX Bio; Merck; Novartis
 
Michael Rahman Shafique
Consulting or Advisory Role - GlaxoSmithKline
 
Hong Zheng
No Relationships to Disclose
 
Wenjie Dai
No Relationships to Disclose
 
Zhihua Chen
No Relationships to Disclose
 
James Joseph Saller
No Relationships to Disclose
 
Nishan Tchekmedyian
Stock and Other Ownership Interests - Biomarin (I); Exelixis (I); global therapeutics (I); Halozyme (I); Infinity Pharmaceuticals (I); Portola Pharmaceuticals; Trillium Therapeutics (I)
Consulting or Advisory Role - IntrinsiQ; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - IntrinsiQ
 
Kristen Goas
No Relationships to Disclose
 
Ram Thapa
No Relationships to Disclose
 
Theresa A. Boyle
Other Relationship - Bristol-Myers Squibb
 
Dung-Tsa Chen
Research Funding - Abbvie (Inst)
 
Amer A Beg
Stock and Other Ownership Interests - Amarin Corporation; Endocyte; Navidea
Consulting or Advisory Role - Vividion Therapeutics
Research Funding - Celgene; Celgene (Inst)
Patents, Royalties, Other Intellectual Property - Moffitt; Moffitt (Inst)
Travel, Accommodations, Expenses - Vividion Therapeutics
 
Jhanelle Elaine Gray
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Genentech/Roche; Janssen; Lilly
Speakers' Bureau - Genentech
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Epic Sciences (Inst); Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche; Janssen Oncology